Clinical Trials Browser

Phase 1/2 × Terminated × Lymphoma, T-Cell, Peripheral × Clear all

Lymphoma, T-Cell, Peripheral, Lymphoma, Extranodal NK-T-Cell

NCT05105412 2024-07-08

Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphomas

Phase 1/2 Terminated

12 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral

NCT02440685 2023-06-07

A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors

Phase 1/2 Terminated

51 enrolled 18 charts

LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, Mantle-Cell, Primary Myelofibrosis

NCT04444141 2022-10-19

A Study of PD-1/CTLA-4 Bispecific AK104 in Relapsed or Refractory Peripheral T-cell Lymphoma

Phase 1/2 Terminated

6 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral

Clinical Trials

TOUCH

Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphomas

A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors

A Study of PD-1/CTLA-4 Bispecific AK104 in Relapsed or Refractory Peripheral T-cell Lymphoma